Wenjie Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 26

Top Topics

Body Mass Index

Left Atrial Appendage

Histone Deacetylase

Basal Cell Carcinoma

Top Venues

Digestive diseases and sciences

Annals of hematology

International immunology

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Wenjie Li, Wei Wang
Toxicity burden patterns of MET-selective tyrosine kinase inhibitors: evidence from real-world pharmacovigilance. Investigational new drugs (2024)
Wenjie Li, Yiming Fu, Wei Wang
A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Annals of hematology (2024)
Wenjie Li, Wei Wang
Revealing the Causal Impact of Obstructive Sleep Apnea on Cancer Risk: Insights from Mendelian randomization analysis. Sleep & breathing = Schlaf & Atmung (2024)
Wenjie Li, Wei Wang
Causal modulation of lipid metabolism may shape the inflammatory microenvironment and potentially augment immunotherapy: a comprehensive genetic landscape revealed by Mendelian randomization analysis. International immunology 36 (6) (2024)
Wenjie Li, Ruxue Lv, Wei Wang
Rheumatoid arthritis was causally related to an increased risk of prostate cancer. International journal of rheumatic diseases 27 (2) (2024)
Wenjie Li, Wei Wang
Causal modulation of lipid metabolism may shape the inflammatory microenvironment and potentially augment immunotherapy: a comprehensive genetic landscape revealed by Mendelian randomization analysis. International immunology 36 (6) (2024)
Wenjie Li, Wei Wang
Causal modulation of lipid metabolism may shape the inflammatory microenvironment and potentially augment immunotherapy: a comprehensive genetic landscape revealed by Mendelian randomization analysis. International immunology (2024)
Wenjie Li, Yiming Fu, Wei Wang
A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Annals of hematology 103 (8) (2024)
Wenjie Li, Yiming Fu, Wei Wang
A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Annals of hematology 103 (8) (2024)
Wenjie Li, Wei Wang
Contribution of High Body Mass Index to the Global Burden of Esophageal Cancer: A Population-Based Study from 1990 to 2019. Digestive diseases and sciences 69 (4) (2024)
Wenjie Li, Wei Wang
Contribution of High Body Mass Index to the Global Burden of Esophageal Cancer: A Population-Based Study from 1990 to 2019. Digestive diseases and sciences 69 (4) (2024)
Wenjie Li, Yiming Fu, Wei Wang
A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors. Annals of hematology 103 (8) (2024)
Wenjie Li, Wei Wang
Revealing the Causal Impact of Obstructive Sleep Apnea on Cancer Risk: Insights from Mendelian randomization analysis. Sleep & breathing = Schlaf & Atmung 28 (4) (2024)
Wenjie Li, Peixin Dong, Wei Wang
Association of systemic inflammation markers in cancer mortality with diabetes: evidence from National Health and Nutrition Examination Survey. Acta diabetologica (2024)
Wenjie Li, Wei Wang
Unravelling the obesity paradox in MASLD patients with extrahepatic cancer. Gut (2024)
Wenjie Li, Wei Wang
Toxicity burden patterns of MET-selective tyrosine kinase inhibitors: evidence from real-world pharmacovigilance. Investigational new drugs 42 (3) (2024)
Wenjie Li, Wei Wang
Toxicity burden patterns of MET-selective tyrosine kinase inhibitors: evidence from real-world pharmacovigilance. Investigational new drugs 42 (3) (2024)
Wenjie Li, Wei Wang
Contribution of High Body Mass Index to the Global Burden of Esophageal Cancer: A Population-Based Study from 1990 to 2019. Digestive diseases and sciences (2024)
Wenjie Li, Ruxue Lv, Wei Wang
Toxicity profiles associated with EGFR-TKIs combined with angiogenesis inhibitors in non-small cell lung cancer: an epidemiological surveillance analysis of the FDA adverse event reporting system. Expert opinion on drug safety (2024)
Wenjie Li, Wei Wang
Contribution of High Body Mass Index to the Global Burden of Esophageal Cancer: A Population-Based Study from 1990 to 2019. Digestive diseases and sciences 69 (4) (2024)
Peixin Dong, Wenjie Li, Jiating Deng, Lixia Huang, Baomo Liu, Shuaishuai Wang, Xiongye Xu, Yan Su, Ziying Lin, Shaoli Li, Jincui Gu, Yanli Qiu, Yanbin Zhou
Relationship between hemoglobin and lung cancer: evidence from Mendelian randomization and National Health and Nutrition Examination Survey. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Wenjie Li, Wei Wang
Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1/programmed cell death-ligand-1. Cancer immunology, immunotherapy : CII (2023)
Wenjie Li, Keshan Wen, Weijie Zhu, Shangfei Luo
A real-world analysis of tyrosine receptor kinase inhibitor-related toxicities in cancer treatment. Personalized medicine (2023)
Wenjie Li, Wei Wang
Unraveling the genetic associations between PD-1/PD-L1 and 13 circulating biomarkers linked to physiological and pathological processes. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Wenjie Li, Wei Wang
Insights into risk factors of basal cell carcinoma: A Mendelian randomization study. Clinical and experimental dermatology (2023)
Yueyun Ma, Wenjie Li, Shiyu Chen, Shuimiao Lin, Sijie Ding, Xiaomei Zhou, Tongxin Liu, Rong Wang, Wei Wang
Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer. International journal of cancer (2022)